Skip to content

4D FDG PET-CT imaging in Esophageal cancer

4D FDG PET-CT imaging in Esophageal cancer - 4D FDG PET in esophageal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41189
Enrollment
30
Registered
2014-08-25
Start date
2015-03-10
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Patients will be imaged with 4D-CT images in addition to the normal protocol of FDG PET-CT image acquisition.

Sponsors

Antoni van Leeuwenhoek Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with pathology proven esophageal cancer or tumor highly suspicious for esophageal cancer - >= 18 years - Wtitten informed consent

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
The estimation of tumor size of the primary esophageal tumor on 4D vs 3D FDG PET.

Secondary

MeasureTime frame
Measurement of SUV max, SUV mean, and SUV peak in 4D versus 3D images of esophageal cancer and lymph nodes and number of suspected involved lymph nodes.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)